Identification of Neurological Prognostic Markers of Cardiac Arrest Patients Alive on 3rd Day (NCT02888184) | Clinical Trial Compass
CompletedNot Applicable
Identification of Neurological Prognostic Markers of Cardiac Arrest Patients Alive on 3rd Day
France130 participantsStarted 2010-01
Plain-language summary
The aim of the study is to identify prognostication predictors of 6-months neurological outcome in survivors at day 3 after cardiac arrest (CA) treated with therapeutic hypothermia (TH).
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* ≥ 18 years
* successfully resuscitated of out-of-hospital cardiac arrest (OHCA)
* patients admitted to ICU
Exclusion Criteria:
* in-hospital cardiac arrest patients
* death before ICU admission
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study was looking for neurological markers in cardiac arrest patients who survived to the third day — if I or my loved one is in a similar situation, could any of the findings from this completed study help predict what my neurological recovery might look like?
2The trial used a scale called the Cerebral Performance Category at 6 months to measure outcomes — can you explain what that scale measures and what range of outcomes it captures, so I understand what 'good' versus 'poor' neurological recovery means in this context?
3Since this study has already been completed, have its results been published, and if so, what did the researchers find about which early markers were most predictive of long-term brain function after cardiac arrest?
4This was an observational study focused on identifying prognostic markers rather than testing a treatment — does that mean its findings might influence how my care team monitors or makes decisions about my neurological recovery, rather than offering a new therapy?
5Are there any current treatment trials or standard-of-care approaches for cardiac arrest survivors that build on this kind of prognostic research, and would those be worth exploring based on my specific situation?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Neurological functional status assessed by the 5-item scale Cerebral Performance Category (CPC) at 6 months.